ONPATTRO

Serial Number 86944919
Registration 5596122
702

Registration Progress

Application Filed
Mar 18, 2016
Under Examination
Oct 4, 2016
Approved for Publication
Aug 9, 2016
Published for Opposition
Aug 9, 2016
Registered
Oct 30, 2018

Basic Information

Serial Number
86944919
Registration Number
5596122
Filing Date
March 18, 2016
Registration Date
October 30, 2018
Published for Opposition
August 9, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 7, 2025
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Henri A. Termeer Square
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Renewal Deadline
1210 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-30)
Due Date
October 30, 2028
Grace Period Ends
April 30, 2029

Application History

32 events
Date Code Type Description
Feb 7, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 7, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 4, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 30, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 30, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 22, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 21, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 9, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 9, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 14, 2018 IUAF S USE AMENDMENT FILED
Aug 14, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 16, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2018 EX3G S SOU EXTENSION 3 GRANTED
Mar 14, 2018 EXT3 S SOU EXTENSION 3 FILED
Mar 14, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2017 EX2G S SOU EXTENSION 2 GRANTED
Sep 19, 2017 EXT2 S SOU EXTENSION 2 FILED
Sep 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 17, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2017 EXT1 S SOU EXTENSION 1 FILED
Mar 15, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 15, 2017 EX1G S SOU EXTENSION 1 GRANTED
Oct 4, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2016 PUBO A PUBLISHED FOR OPPOSITION
Jul 20, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2016 DOCK D ASSIGNED TO EXAMINER
Mar 23, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
First Use Anywhere: Aug 13, 2018
First Use in Commerce: Aug 13, 2018

Classification

International Classes
005